Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-01

Clinical Trial Update: Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating doxepin hydrochloride for treating esophageal pain in thoracic cancer patients receiving radiation therapy (with or without ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DOXEPIN HYDROCHLORIDE (doxepin hydrochloride)

Snippet

Sponsor: Mayo Clinic | Conditions: Esophageal Carcinoma, Hypopharyngeal Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2019-10-01